Title:
PD-L1 BINDING MOLECULE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/072213
Kind Code:
A1
Abstract:
A PD-L1 binding molecule and an application thereof, relating to the technical field of monoclonal antibodies. Provided are a preparation method for the PD-L1 binding molecule, a use of the PD-L1 binding molecule, and a kit, immune conjugate, and pharmaceutical composition containing the PD-L1 binding molecule.
Inventors:
YAN JIAQING (CN)
LI YANMIN (CN)
ZHANG LILI (CN)
HUO YONGTING (CN)
LU LISHENG (CN)
LI YANMIN (CN)
ZHANG LILI (CN)
HUO YONGTING (CN)
LU LISHENG (CN)
Application Number:
PCT/CN2022/128027
Publication Date:
May 04, 2023
Filing Date:
October 27, 2022
Export Citation:
Assignee:
GUANGDONG FEIPENG PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K16/46; C07K19/00; C12N15/13; C12N15/63
Domestic Patent References:
| WO2020259566A1 | 2020-12-30 |
Foreign References:
| CN111116747A | 2020-05-08 | |||
| CN113045662A | 2021-06-29 | |||
| CN109265548A | 2019-01-25 | |||
| CN112409483A | 2021-02-26 | |||
| US20210261667A1 | 2021-08-26 | |||
| US20200148772A1 | 2020-05-14 |
Attorney, Agent or Firm:
KANGXIN PARTNERS, P.C. (CN)
Download PDF: